跳至主要内容
临床试验/NCT02732106
NCT02732106Unknown不适用

Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease

Cytori Therapeutics4 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
4
主要终点
Adipose-Derived Regenerative Cells (ADRCs)- Cell Characterization

研究概览

简要总结

Human adipose tissue is now recognized as an acceptable, highly abundant source of adipose-derived regenerative cells (ADRCs). ADRCs are a heterogeneous or mixed population of cells found in adipose tissue including adult stem cells, leukocytes, connective tissue and vessel-associated cells. Autologous adult regenerative cells are thought to promote healing of scarred or injured tissue. While the investigators are learning more about the exact mechanisms every day, it is believed that this heterogeneous population of cells influences the local environment via cell-to-cell signaling, immune modulation, and differentiation into other cell types. The use of ADRCs in the treatment of many different medical conditions (including cardiovascular disease, soft tissue defects, wound healing, and many more) is being evaluated in numerous clinical and preclinical studies around the world. While there is a considerable amount of information regarding the cellular composition of ADRCs isolated from healthy donors, basically there is no much data regarding the ADRC composition from cardiac patients. In this study, adipose tissue or cells from chronic heart ischemia patients, that would otherwise be thrown away in waste, will be provided to researchers who will study these cells with the objective to characterize ADRCs derived from patients with a heart disease and to compare if a heart disease state does impact ADRC cell composition.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients enrolled in the ATHENA clinical trial that donated their leftover material to be studied.

排除标准

  • 未提供

结局指标

主要结局

Adipose-Derived Regenerative Cells (ADRCs)- Cell Characterization

时间窗: Day 1

Cells will be evaluated regarding cell composition by flow cytometric assays.

次要结局

未报告次要终点

研究者

发起方
Cytori Therapeutics
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

已完成
不适用
Factors That Influence Adipose Derived Regenerative Cells' Yield and ViabilityProblem of AgingSmokingPhysical ActivityGender
NCT02651233Clinical Centre of Serbia46
Unknown
1 期
Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb IschemiaCritical Limb IschemiaThromboangiitis ObliteransDiabetic AngiopathiesPeripheral Arterial DiseaseArteriosclerosis Obliterans
NCT02864654Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation9
已完成
不适用
clinical results of adipose-derived regenerative cell therapy for osteoarthritisosteoarthritis
JPRN-UMIN000033510Kanazawa University50
进行中(未招募)
不适用
A clinical evaluation of adipose derived Regenerative cells in the treatment of patients with brEast deformities post Segmental breast resection (lumpectomy) with Or without Radiation therapy. A phase IV post market study – the RESTORE 2 trialEvaluación clínica de células regenerativas derivadas de tejido adiposo para el tratamiento de pacientes con deformidades mamarias tras mastectomia segmentaria (cuadrantectomia) con o sin radioterapia. Un ensayo fase IV de farmacovigilancia – Ensayo RESTORE -2 - RESTORE-2Pacientes con deformidades mamarias tras mastectomía segmentaria (cuadrantectomía) con o sin radioterapia
EUCTR2007-007956-33-ESCytori Therapeutics Inc70
已完成
不适用
Fat Grafts With Adipose-derived Regenerative Cells for Soft Tissue Reconstruction in ChildrenCraniofacial Microsomia
NCT03806361Hospital Sirio-Libanes30